ROCHESTER, Mich. , May 15, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will participate in the following upcoming investor
Total revenue of $13.0 million GAAP net loss per share of $(0.37) Non-GAAP net loss per share of $(0.09) ROCHESTER, Mich. , May 10, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on
Physicians report that they are encountering brand information across multiple digital and in-person channels, yet still lack key information on patient eligibility, affordability, and access ROCHESTER, Mich. , May 02, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp .
ROCHESTER, Mich. , April 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy will hold a conference call on Wednesday, May 10, 2023 at 4:30 p.m.
ROCHESTER, Mich. , April 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy has published its 2023 Environmental, Social and Governance (ESG) report .
– AI driven RWD deals grow from 6 completed in 2022 to several dozen in pipeline today, representing the rapid adoption of OptimizeRx’s health technology enablement platform services ROCHESTER, Mich. , March 29, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading
ROCHESTER, Mich. , March 14, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase
Deal will enable high-growth patient services company to streamline and enhance its services with OptimizeRx’s technology solutions ROCHESTER, Mich. , March 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions
Q4 revenue of $19.7 million , down 3% year-over-year and up 30% quarter-over-quarter Q4 gross profit increased 1% year-over-year to $12.5 million as gross margins increased from 61% to 63% Generated $10.7 million in cash flow from operations in 2022 Repurchased 1.2 million shares during 2022 at an
ROCHESTER, Mich. , Feb. 23, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wednesday, March 8, 2023 at 4:30 p.m.